Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1216200.RA_gtR_xPhDYWwY1QIp-Nn7Z7Yw0XgpQVZbj-ufIYZyJg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1216200.RA_gtR_xPhDYWwY1QIp-Nn7Z7Yw0XgpQVZbj-ufIYZyJg130_assertion type Assertion NP1216200.RA_gtR_xPhDYWwY1QIp-Nn7Z7Yw0XgpQVZbj-ufIYZyJg130_head.
- NP1216200.RA_gtR_xPhDYWwY1QIp-Nn7Z7Yw0XgpQVZbj-ufIYZyJg130_assertion description "[Among 45 BCC and 35 TE examined, expression levels were respectively 81% and 57% (BNIP3), 73% and 75% (CAIX), 79% and 86% (GLUT1), 50% and 19% (HIF1?), 89% and 88% (pAKT), 55% and 61% (pS6), 15% and 25% (pMTOR), 44% and 63% (PHD2) and 44% and 49% (VEGF-A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216200.RA_gtR_xPhDYWwY1QIp-Nn7Z7Yw0XgpQVZbj-ufIYZyJg130_provenance.
- NP1216200.RA_gtR_xPhDYWwY1QIp-Nn7Z7Yw0XgpQVZbj-ufIYZyJg130_assertion evidence source_evidence_literature NP1216200.RA_gtR_xPhDYWwY1QIp-Nn7Z7Yw0XgpQVZbj-ufIYZyJg130_provenance.
- NP1216200.RA_gtR_xPhDYWwY1QIp-Nn7Z7Yw0XgpQVZbj-ufIYZyJg130_assertion SIO_000772 25181405 NP1216200.RA_gtR_xPhDYWwY1QIp-Nn7Z7Yw0XgpQVZbj-ufIYZyJg130_provenance.
- NP1216200.RA_gtR_xPhDYWwY1QIp-Nn7Z7Yw0XgpQVZbj-ufIYZyJg130_assertion wasDerivedFrom befree-2016 NP1216200.RA_gtR_xPhDYWwY1QIp-Nn7Z7Yw0XgpQVZbj-ufIYZyJg130_provenance.
- NP1216200.RA_gtR_xPhDYWwY1QIp-Nn7Z7Yw0XgpQVZbj-ufIYZyJg130_assertion wasGeneratedBy ECO_0000203 NP1216200.RA_gtR_xPhDYWwY1QIp-Nn7Z7Yw0XgpQVZbj-ufIYZyJg130_provenance.